Fate Therapeutics

FATE

NASDAQHealth Care

Income Statement

Total Revenue$13.63M

Gross Profit$13.63M

Operating Income$-210.28M

EBITDA$-167.3M

EBIT$-186.26M

Pre-tax Income$-129.91M

Net Income$-186.26M

Cash Equivalent$70.75M

Total Debt$96.72M

Book Value$376.04M

Book Value Per Share3.41

Return on Equity (ROE)-58.44%

Return on Assets (ROA)-42.27%

Return on Invested Capital (ROI)-58.44%

Net Profit Margin-1366.46%

Current Ratio7.58

Quick Ratio7.34

Long-Term Debt / Equity0.00